CENTESSA PHARMACEUTICALS-ADR (CNTA) Top Institutional Shareholders
CENTESSA PHARMACEUTICALS-ADR (CNTA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $5.86B in CNTA holdings during the latest filing period.
Medicxi Ventures Management (Jersey) Ltd is currently the largest disclosed institutional shareholder of CNTA tracked by InsiderSet, reporting ownership valued at approximately $792.94M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $795.93M, representing an estimated gain of +0.38% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 58% of the total disclosed CNTA value among the investors covered in this analysis. Major shareholders include Medicxi Ventures Management (Jersey) Ltd, Avoro Capital Advisors Llc, Index Venture Life Associates Vi Ltd, and several other long-term asset managers with concentrated positions in CENTESSA PHARMACEUTICALS-ADR (CNTA).
This page ranks the largest institutional CNTA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
159
Total Reported Value
$5.86B
Largest Holder
Medicxi Ventures Management (Jersey) Ltd
Largest Position
$792.94M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
192
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 80.76% | 19,963,157 | $792,936,596 | $795,931,070 | +$2,994,474 | +0.38% | |
| Avoro Capital Advisors Llc | 4.47% | 11,430,455 | $454,017,673 | $455,732,241 | +$1,714,568 | +0.38% | |
| Index Venture Life Associates Vi Ltd | 100.00% | 9,961,789 | $395,682,259 | $397,176,527 | +$1,494,268 | +0.38% | |
| Adage Capital Partners Gp, L.L.C. | 0.55% | 8,925,010 | $354,501,397 | $355,840,149 | +$1,338,752 | +0.38% | |
| Pentwater Capital Management Lp | 2.31% | 8,170,000 | $324,512,400 | $325,737,900 | +$1,225,500 | +0.38% | |
| Fmr Llc | 0.01% | 6,852,047 | $272,163,307 | $273,191,114 | +$1,027,807 | +0.38% | |
| Ecor1 Capital, Llc | 10.18% | 6,000,000 | $238,320,000 | $239,220,000 | +$900,000 | +0.38% | |
| Perceptive Advisors Llc | 4.13% | 5,258,903 | $208,883,627 | $209,672,463 | +$788,836 | +0.38% | |
| Capital World Investors | 0.03% | 4,832,548 | $191,948,807 | $192,673,689 | +$724,882 | +0.38% | |
| Farallon Capital Management Llc | 1.24% | 4,809,000 | $191,013,480 | $191,734,830 | +$721,350 | +0.38% | |
| Tcg Crossover Management, Llc | 4.87% | 4,286,480 | $170,258,986 | $170,901,958 | +$642,972 | +0.38% | |
| Morgan Stanley | 0.01% | 4,268,353 | $169,538,989 | $170,179,234 | +$640,245 | +0.38% | |
| Paradigm Biocapital Advisors Lp | 2.90% | 3,574,048 | $141,961,187 | $142,497,294 | +$536,107 | +0.38% | |
| Janus Henderson Group Plc | 0.07% | 3,492,977 | $138,741,046 | $139,264,993 | +$523,947 | +0.38% | |
| Deep Track Capital, Lp | 2.59% | 3,158,041 | $125,437,389 | $125,911,095 | +$473,706 | +0.38% | |
| Logos Global Management Lp | 4.35% | 2,125,000 | $84,405,000 | $84,723,750 | +$318,750 | +0.38% | |
| Rtw Investments, Lp | 0.81% | 2,054,175 | $81,591,831 | $81,899,957 | +$308,126 | +0.38% | |
| Federated Hermes, Inc. | 0.13% | 2,049,439 | $81,403,717 | $81,711,133 | +$307,416 | +0.38% | |
| Braidwell Lp | 2.63% | 1,986,768 | $78,914,425 | $79,212,440 | +$298,015 | +0.38% | |
| Bank Of America Corp | 0.01% | 1,932,406 | $76,755,166 | $77,045,027 | +$289,861 | +0.38% | |
| Maverick Capital Ltd | 0.86% | 1,854,488 | $73,660,263 | $73,938,437 | +$278,174 | +0.38% | |
| First Light Asset Management, Llc | 5.56% | 1,560,991 | $62,002,563 | $62,236,711 | +$234,148 | +0.38% | |
| Affinity Asset Advisors, Llc | 3.26% | 1,400,000 | $55,608,000 | $55,818,000 | +$210,000 | +0.38% | |
| Foresite Capital Management Vi Llc | 11.77% | 1,364,019 | $54,178,835 | $54,383,438 | +$204,603 | +0.38% | |
| General Atlantic, L.P. | 2.50% | 1,354,830 | $53,813,848 | $54,017,072 | +$203,224 | +0.38% | |
| Goldman Sachs Group Inc | 0.01% | 1,144,560 | $45,461,923 | $45,633,607 | +$171,684 | +0.38% | |
| Siren, L.L.C. | 1.16% | 1,053,464 | $41,843,590 | $42,001,610 | +$158,020 | +0.38% | |
| Cormorant Asset Management, Lp | 2.10% | 1,050,000 | $41,706,000 | $41,863,500 | +$157,500 | +0.38% | |
| Alpine Associates Management Inc. | 2.03% | 865,500 | $34,377,660 | $34,507,485 | +$129,825 | +0.38% | |
| Woodline Partners Lp | 0.13% | 859,105 | $34,123,651 | $34,252,516 | +$128,865 | +0.38% | |
| Balyasny Asset Management L.P. | 0.07% | 852,828 | $33,874,328 | $34,002,252 | +$127,924 | +0.38% | |
| Octagon Capital Advisors Lp | 3.30% | 750,000 | $29,790,000 | $29,902,500 | +$112,500 | +0.38% | |
| Millennium Management Llc | 0.02% | 722,121 | $28,682,646 | $28,790,964 | +$108,318 | +0.38% | |
| Bnp Paribas Asset Management Holding S.A. | 0.03% | 702,254 | $27,893,529 | $27,998,867 | +$105,338 | +0.38% | |
| American Century Companies Inc | 0.01% | 687,427 | $27,304,699 | $27,407,714 | +$103,015 | +0.38% | |
| Franklin Resources Inc | 0.01% | 684,482 | $27,187,639 | $27,290,297 | +$102,658 | +0.38% | |
| Baker Bros. Advisors Lp | 0.15% | 670,751 | $26,642,230 | $26,742,842 | +$100,612 | +0.38% | |
| Eventide Asset Management, Llc | 0.44% | 668,142 | $26,538,600 | $26,638,822 | +$100,222 | +0.38% | |
| Toronto Dominion Bank | 0.05% | 654,850 | $26,010,642 | $26,108,870 | +$98,228 | +0.38% | |
| Tig Advisors, Llc | 1.23% | 648,326 | $25,751,509 | $25,848,758 | +$97,249 | +0.38% | |
| D. E. Shaw & Co., Inc. | 0.02% | 643,808 | $25,572,054 | $25,668,625 | +$96,571 | +0.38% | |
| Bain Capital Life Sciences Investors, Llc | 2.27% | 635,000 | $25,222,200 | $25,317,450 | +$95,250 | +0.38% | |
| Qube Research & Technologies Ltd | 0.04% | 628,049 | $24,946,106 | $25,040,314 | +$94,208 | +0.38% | |
| Blackrock, Inc. | 0.00% | 625,420 | $24,841,683 | $24,935,495 | +$93,812 | +0.38% | |
| Citadel Advisors Llc | 0.02% | 598,197 | $23,760,385 | $23,850,114 | +$89,729 | +0.38% | |
| 5Am Venture Management, Llc | 6.41% | 580,945 | $23,075,135 | $23,162,277 | +$87,142 | +0.38% | |
| Pfm Health Sciences, Lp | 2.21% | 528,224 | $20,981,057 | $21,060,291 | +$79,234 | +0.38% | |
| Weiss Asset Management Lp | 0.37% | 510,407 | $20,273,366 | $20,349,927 | +$76,561 | +0.38% | |
| Spruce Street Capital Lp | 4.68% | 489,849 | $19,456,802 | $19,530,280 | +$73,478 | +0.38% | |
| Silverarc Capital Management, Llc | 2.18% | 466,345 | $18,523,223 | $18,593,175 | +$69,952 | +0.38% |
Frequently asked questions about CNTA
Who owns the most CNTA stock?
The largest holders of CNTA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for CENTESSA PHARMACEUTICALS-ADR (CNTA).
Is CNTA widely held by superinvestors?
Many widely followed stocks like CNTA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CNTA is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.